Analysts expect that Healthequity Inc (NASDAQ:HQY) will report sales of $83.98 million for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Healthequity’s earnings. The highest sales estimate is $86.00 million and the lowest is $82.28 million. Healthequity posted sales of $69.90 million during the same quarter last year, which suggests a positive year-over-year growth rate of 20.1%. The business is expected to issue its next earnings report after the market closes on Tuesday, June 4th.
According to Zacks, analysts expect that Healthequity will report full-year sales of $337.42 million for the current year, with estimates ranging from $336.70 million to $339.12 million. For the next financial year, analysts forecast that the company will post sales of $388.57 million, with estimates ranging from $384.33 million to $393.70 million. Zacks’ sales calculations are a mean average based on a survey of analysts that cover Healthequity.
Healthequity (NASDAQ:HQY) last released its quarterly earnings data on Monday, March 18th. The company reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.15 by $0.06. The company had revenue of $75.78 million during the quarter, compared to analyst estimates of $74.28 million. Healthequity had a net margin of 25.73% and a return on equity of 13.59%. Healthequity’s revenue for the quarter was up 25.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.09 EPS.
Several analysts have recently weighed in on HQY shares. Chardan Capital reiterated a “buy” rating and issued a $78.00 price objective (down previously from $82.00) on shares of Healthequity in a research note on Thursday, February 7th. SunTrust Banks upgraded shares of Healthequity from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a research note on Thursday, February 7th. BidaskClub lowered shares of Healthequity from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 30th. Zacks Investment Research upgraded shares of Healthequity from a “strong sell” rating to a “hold” rating in a research note on Tuesday, May 21st. Finally, Bank of America reiterated a “neutral” rating and issued a $82.00 price objective (up previously from $67.00) on shares of Healthequity in a research note on Friday, March 1st. Four investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $88.33.
Shares of NASDAQ:HQY traded up $1.26 during mid-day trading on Friday, hitting $69.11. The company had a trading volume of 783,754 shares, compared to its average volume of 848,916. The firm has a market capitalization of $4.33 billion, a P/E ratio of 72.75, a P/E/G ratio of 3.00 and a beta of 1.62. Healthequity has a one year low of $50.29 and a one year high of $101.58.
In related news, VP Darcy G. Mott sold 4,000 shares of Healthequity stock in a transaction on Monday, April 22nd. The shares were sold at an average price of $66.28, for a total value of $265,120.00. Following the completion of the sale, the vice president now owns 69,500 shares of the company’s stock, valued at approximately $4,606,460. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In the last three months, insiders sold 12,000 shares of company stock valued at $876,200. 3.70% of the stock is currently owned by insiders.
A number of institutional investors and hedge funds have recently bought and sold shares of HQY. Jackson Square Partners LLC purchased a new position in Healthequity during the 1st quarter worth $128,524,000. Norges Bank purchased a new position in Healthequity during the 4th quarter worth $29,950,000. Wasatch Advisors Inc. boosted its holdings in Healthequity by 22.6% during the 1st quarter. Wasatch Advisors Inc. now owns 2,038,929 shares of the company’s stock worth $150,840,000 after acquiring an additional 376,461 shares during the last quarter. Wells Fargo & Company MN boosted its holdings in Healthequity by 40.8% during the 1st quarter. Wells Fargo & Company MN now owns 962,572 shares of the company’s stock worth $71,212,000 after acquiring an additional 279,115 shares during the last quarter. Finally, SEI Investments Co boosted its holdings in Healthequity by 11,935.4% during the 1st quarter. SEI Investments Co now owns 273,685 shares of the company’s stock worth $20,243,000 after acquiring an additional 271,411 shares during the last quarter. 96.76% of the stock is currently owned by hedge funds and other institutional investors.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Read More: Should I follow buy, hold and sell recommendations?
Get a free copy of the Zacks research report on Healthequity (HQY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.